ARTICLE | Distillery Therapeutics
Infectious disease
October 25, 2018 6:02 PM UTC
In vitro and cell culture studies identified kanglemycin-based RNAP inhibitors that could help treat rifamycin-resistant bacterial infections. In silico screening of soil bacteria genomes for gene clu...
BCIQ Company Profiles
BCIQ Target Profiles